atopic-dermatitis

Documents about atopic-dermatitis

• A Phase 2 Study of PH-10 for the Treatment of Atopic Dermatitis#853636ClinicalTrials.gov
• Twice Daily Versus Twice Weekly Soak-and-Seal Baths in Pediatric Atopic Dermatitis#856912ClinicalTrials.gov
• Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis#876604ClinicalTrials.gov
• Efficacy of Fermented Rice Flour for the Treatment of Atopic Dermatitis#914956ClinicalTrials.gov
• Safety, Tolerability and Pharmacokinetics of LNK01004 Ointment in Adults With Atopic Dermatitis.#995099ClinicalTrials.gov
• Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2)#1007183ClinicalTrials.gov
• Evaluate Efficacy, PK, and Safety of FB825 in Adults With Atopic Dermatitis#1010386ClinicalTrials.gov
• ICP-332 in Subjects With Moderate to Severe Atopic Dermatitis#1030015ClinicalTrials.gov
• Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy#834507ClinicalTrials.gov
• A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis#870451ClinicalTrials.gov
• Oregano Ointment vs. Standard Treatment for Pediatric Atopic Dermatitis#881329ClinicalTrials.gov
• Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis#811468ClinicalTrials.gov
• Immune Response to Yellow Fever Vaccination in Adults With Atopic Dermatitis#451506ClinicalTrials.gov
• Monoclonal Antibodies in Pediatric Atopic Dermatitis; Efficacy and Safety#478485Europe PMC
• A Long-term Trial of OPA-15406 in Infants With Atopic Dermatitis#828069ClinicalTrials.gov
• Safety, Pharmacokinetics and Efficacy of FMX114 Versus Vehicle in Adults With Atopic Dermatitis#846328ClinicalTrials.gov
• Safety and Tolerability of BSI-045B in Healthy Adult Subjects and Patients With Atopic Dermatitis#847710ClinicalTrials.gov
• Atopic Dermatitis Research Network (ADRN) Influenza Vaccine Pilot#872131ClinicalTrials.gov
• Efficacy and Safety Study of Orally Administered DS107 in Moderate to Severe Atopic Dermatitis Patients#892060ClinicalTrials.gov
• A Phase 1b Study Assessing the PK, PD, Safety & Tolerability of SB414 in Atopic Dermatitis#906640ClinicalTrials.gov
• Tacrolimus Ointment Long Term Safety in Young Children With Atopic Dermatitis#912874ClinicalTrials.gov
• Efficacy of Acupuncture in the Treatment of Moderate-to-severe Atopic Dermatitis#967293ClinicalTrials.gov
• Neuropsychologic Assessments of Dupilumab-Treated Adolescent Participants With Moderate-to-Severe Atopic Dermatitis#1008471ClinicalTrials.gov
• Real-world Effectiveness Study of Long-term Treatment With Dupilumab in Participants ≥6 Years With Atopic Dermatitis#1032244ClinicalTrials.gov
• The UPDATE Trial (Uvb Phototherapy in Dermatology for ATopic Eczema)#873020ClinicalTrials.gov
• Evaluation of 611 in Combination With Topical Corticosteroid in Participants With Moderate to Severe Atopic Dermatitis#1009662ClinicalTrials.gov
• CBP-201 in Adolescent and Adult Patients With Moderate-to-severe Atopic Dermatitis#856472ClinicalTrials.gov
• ADRN Barrier/Immunoprofiling Exploratory Pilot Study#230454ClinicalTrials.gov
• A Study to Evaluate the Safety and Efficacy of ATx201 in Subjects With Moderate Atopic Dermatitis#803343ClinicalTrials.gov
• Clinical Evaluation of Skin Microbiome an Over-The-Counter (OTC) Drug for Atopic Dermatitis#804190ClinicalTrials.gov
• Open-Label,Singel Center Study of Alefacept in Patients With Atopic Dermatitis#812396ClinicalTrials.gov
• Impact of Vitamin D Supplementation on Severity of Pediatric Atopic Dermatitis#825210ClinicalTrials.gov
• Replication of the Heads Up Atopic Dermatitis Trial With Registry Data#843507ClinicalTrials.gov
• The Impact of Dupilumab Treatment on Anxiety and Depression Symptoms in Patients With Moderate-to-Severe Atopic Dermatitis#860214ClinicalTrials.gov
• Safety of ADSTEM Injection in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis#872313ClinicalTrials.gov
• Evaluation of Cutaneous and Circulating Inflammatory Biomarkers in Hidradenitis Suppurativa and Atopic Dermatitis#872499ClinicalTrials.gov
• Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (Integument-PED)#872540ClinicalTrials.gov
• A Study to Evaluate ABT-494 (Upadacitinib) in Adults With Moderate to Severe Atopic Dermatitis#874486ClinicalTrials.gov
• Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (INTEGUMENT-II)#887260ClinicalTrials.gov
• Dupilumab and House Dust Mite Immunotherapy in Patients With Atopic Dermatitis#894798ClinicalTrials.gov
• A Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis#895324ClinicalTrials.gov
• Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus Ointment#895442ClinicalTrials.gov
• A Clinical Study to Evaluate SM17 for Atopic Dermatitis#905436ClinicalTrials.gov
• Study to Determine the Safety and Effectiveness of Dupilumab for Treatment of Atopic Dermatitis (AD)#905974ClinicalTrials.gov
• Study of MG-K10 Humanized Monoclonal Antibody Injection in Patients With Atopic Dermatitis#906547ClinicalTrials.gov
• Treatment and Medical Care of Patients With Moderate-to-severe Atopic Dermatitis - TREATswitzerland#912562ClinicalTrials.gov
• Efficacy and Safety of Orally Administered DS107 in Adult Patients With Moderate to Severe Atopic Dermatitis#970046ClinicalTrials.gov
• Dilute Bleach Baths in Pediatric Patients With Atopic Dermatitis#1010121ClinicalTrials.gov
• Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE AD1) - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis#854087ClinicalTrials.gov
• A Study to Assess the Safety and Efficacy of ZPL389 in Patients With Moderate to Severe Atopic Dermatitis#911746ClinicalTrials.gov